PDCD1 and lung cancer: In the present investigation, we looked at the effects of QFM combined with PD-1 inhibitor on tryptophan metabolic reprogramming pathway in vitro and in vivo, which provided a novel route for the synergistic immunotherapy research of QFM in lung cancer.